Farley is a first time rider on the 2022 Road to Victories team. He is an Executive Immunology Specialist with Janssen Immunology. He is a long time rider for the MS Society and is looking forward to joining forces with the MRF to raise money and awareness about Multiple Myeloma. He says a ride of this distance and elevation will be a challenge for him, but is nothing compared to the challenge faced by patients with Multiple Myeloma.
At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.About Janssen Oncology
Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.Learn More